Allspring Global Investments
OMGA

Allspring Global Investments’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Allspring Global Investments’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,577
Closed -$5.54K – 2805
2023
Q3 		$5.54K Buy
+2,577
New +$10.3K ﹤0.01% 2668
2022
Q2 		– Sell
-14,030
Closed -$87K – 2977
2022
Q1 		$87K Sell
14,030
-1,663
-11% -$17K ﹤0.01% 2773
2021
Q4 		$177K Buy
+15,693
New +$298K ﹤0.01% 2655

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Allspring Global Investments's OMGA Position: Q4 2023 in Review

Allspring Global Investments sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2023, closing a stake of 2,577 shares — an estimated $5.54K sold.

Allspring Global Investments first reported a position in OMGA in Q4 2021 and held it in 3 quarters. The position peaked at $177K in Q4 2021. 63 funds tracked by Wall St. Rank hold OMGA as of Q4 2023.

  • Allspring Global Investments reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 2,577 Omega Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $5.54K.
  • Allspring Global Investments first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's Omega Therapeutics, Inc. Common Stock position peaked at $177K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.